Valeant Commits $200,000 to Support Hurricane Relief Efforts

LAVAL, Quebec, Sept. 15, 2017

LAVAL, Quebec, Sept. 15, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced the Company and its employees through a matching donation program will donate $200,000 to the American Red Cross to support its efforts in the areas affected by Hurricanes Harvey and Irma. Additionally, Valeant has worked with Americares to donate more than $2 million of critically needed medicines and over-the-counter health care products to people in need in these areas.

"Our thoughts and prayers are with the people of Texas, the Gulf Coast and Florida, including some of our employees, who have been impacted by these destructive storms," said Joseph C. Papa, chairman and CEO, Valeant. "We are glad to support both the American Red Cross and Americares. Additionally, I am especially proud of the response by our employees, some of whom traveled to the affected areas to volunteer in the relief efforts."

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Investor Contact:	Media Contact: ARIVA.DE Börsen-Geflüster Kurse Bausch Health Companies 8,545 $ -0,18%
Arthur Shannon	Lainie Keller
arthur.shannon@valeant.com	lainie.keller@valeant.com
(514) 856-3855	(908) 927-0617
(877) 281-6642 (toll free)

View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-commits-200000-to-support-hurricane-relief-efforts-300520405.html

SOURCE Valeant Pharmaceuticals International, Inc.